Indaptus Therapeutics, Inc. Marketable Securities (Current)
Indaptus Therapeutics, Inc. (INDP) had Marketable Securities (Current) of $6.99 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-03-13
- 2023-06-30: Marketable Securities, Current $6.99M.
- 2023-03-31: Marketable Securities, Current $14.88M.
- 2022-12-31: Marketable Securities, Current $16.81M.
- 2022-09-30: Marketable Securities, Current $21.74M.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-06-30 | $6.99M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $14.88M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $16.81M 10-K · filed 2024-03-13 |
| 2022-09-30 | $21.74M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $18.75M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.96M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |